BEGIN:VCALENDAR VERSION:2.0 PRODID:-//NephU - ECPv6.1.4//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:NephU X-ORIGINAL-URL:https://nephu.org X-WR-CALDESC:Events for NephU REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20210314T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20211107T060000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20211021T210000 DTEND;TZID=America/New_York:20211021T220000 DTSTAMP:20240328T070948 CREATED:20210911T043309Z LAST-MODIFIED:20211022T151332Z UID:11503-1634850000-1634853600@nephu.org SUMMARY:Polycystic Kidney Disease Research - Past\, Present & Future: Part II DESCRIPTION:Over the past 50 years there has been significant advancement in Polycystic Kidney Disease (PKD) research which has allowed for the translation of these findings into not only an increased awareness of the disease but also improvements in clinical management.  During “Polycystic Kidney Disease Research – Past\, Present and Future: Part I”\, we heard from leading experts\, James Calvet\, PhD and Arlene Chapman\, MD\, on the past scientific discoveries and clinical advancements made within the field of PKD research.  \n\n\n\nWith all of these impressive accomplishments\, leaders in the field know we must not become complacent but instead push the field even further forward in hopes of greater awareness\, more management options\, and improved patient outcomes. Join us for Part II of our “Polycystic Kidney Disease Research – Past\, Present\, and Future” webinar where talented and emerging experts\, Vishal Patel\, MD & Katharina Hopp\, PhD discuss efforts being made to further elucidate the molecular pathways contributing to disease and shed light on cutting edge research that may one day lead to improved options for patients living with PKD. \n\n\n\n*Dr Hopp is a paid consultant of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC). Dr Patel is an unpaid consultant of ODPC. Dr Hajarnis is an employee of OPDC. \n\n\n\n You must be logged in to register for this event.\nPlease Log In or Join Now\n \n Join To View\n Already A Member? Login\n \n \n\n\n\n\n\n\nFeatured Speakers\n\n\n\n\n\n\n\n \n \n \n Sachin Hajarnis\, PhD\n Nephrology Senior Medical Science Liaison\n \n \n \n \n \nOtsuka Pharmaceutical Development & Commercialization\, Inc.*\n \n \n Sachin Hajarnis\, PhD is a Senior Medical Science Liaison at Otsuka Pharmaceuticals. Dr Hajarnis has a Bachelors and Masters in Life Sciences from University of Mumbai\, India. He obtained a PhD in Biochemistry and Molecular Biology from Colorado State University. Dr Hajarnis joined the University of Texas Southwestern Medical school in Dallas\, as a post-doctoral fellow in the department of Nephrology where he performed basic research on various aspects of Polycystic Kidney Disease (PKD). He continued his studies on the role of micro-RNAs in PKD as a Research Scientist for several years before joining his current position at Otsuka. \n\n \n \n\n\nLocation\n\n\n\nOnline URL:https://nephu.org/event/polycystic-kidney-disease-research-past-present-future-part-ii-900-pm-et-session/ CATEGORIES:Webinar ATTACH;FMTTYPE=image/jpeg:https://nephu.org/wp-content/uploads/2020/11/Casual-Laptop_resize.jpg END:VEVENT END:VCALENDAR